Evidence map›Paper›PMID 34432559›Full record

ArticlemAbs

Accurate determination of epitope for antibodies with unknown 3D structures.

Shifa Tahir, Thomas Bourquard, Astrid Musnier, Yann Jullian, Yannick Corde, Zakaria Omahdi, Laetitia Mathias, Eric Reiter, Pascale Crépieux, Gilles Bruneau and 1 more

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Recent Progress in Antibody Epitope Prediction.Antibodies (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. VInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shifa TahirPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Thomas BourquardPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Astrid MusnierPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Yann JullianMAbSilico SAS, 1 Impasse Du Palais.
Yannick CordeMAbSilico SAS, 1 Impasse Du Palais.
Zakaria OmahdiMAbSilico SAS, 1 Impasse Du Palais.
Laetitia MathiasPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Eric ReiterPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Pascale CrépieuxPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Gilles BruneauPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.
Anne PouponPRC, INRAE, CNRS, Université De Tours, Nouzilly, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAbTope is a docking-based method for the determination of epitopes. It has been used to successfully determine the epitopes of antibodies with known 3D structures. However, during the antibody discovery process, this structural information is rarely available. Although we already have evidence that homology models of antibodies could be used instead of their 3D structure, the choice of the template, the methodology for homology modeling and the resulting performance still have to be clarified. Here, we show that MAbTope has the same performance when working with homology models of the antibodies as compared to crystallographic structures. Moreover, we show that even low-quality models can be used. We applied MAbTope to determine the epitope of dupilumab, an anti- interleukin 4 receptor alpha subunit therapeutic antibody of unknown 3D structure, that we validated experimentally. Finally, we show how the MAbTope-determined epitopes for a series of antibodies targeting the same protein can be used to predict competitions, and demonstrate the accuracy with an experimentally validated example.3D: three-dimensionalRMSD: root mean square deviationCDR: complementary-determining regionCPU: central processing unitsVH: heavy chain variable regionVL: light chain variable regionscFv: single-chain variable fragmentsVHH: single-chain antibody variable regionIL4Rα: Interleukin 4 receptor alpha chainSPR: surface plasmon resonancePDB: protein data bankHEK293: Human embryonic kidney 293 cellsEDTA: Ethylenediaminetetraacetic acidFBS: Fetal bovine serumANOVA: Analysis of varianceEGFR: Epidermal growth factor receptorPE: PhycoerythrinAPC: AllophycocyaninFSC: forward scatterSSC: side scatterWT: wild typeKeywords: MAbTope, Epitope Mapping, Molecular docking, Antibody modeling, Antibody-antigen docking.

Indexed as

Epitope MappingEpitopesMolecular Docking SimulationAntibodies, Monoclonal, HumanizedAntigensBinding Sites, AntibodyErbB ReceptorsHEK293 CellsHumansInterleukin-4 Receptor alpha SubunitMutationProtein BindingProtein ConformationStructure-Activity RelationshipAntibodies, Monoclonal, HumanizedAntigensdupilumabEGFR protein, humanEpitopesErbB ReceptorsInterleukin-4 Receptor alpha SubunitnecitumumabAntibodyartificial intelligencebioinformaticsdupilimumabepitope binningEpitope mapping

Identifiers

PMID34432559
PMCPMC8405158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.